Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotinamide add-on therapy vs placebo in dialysis-dependent patients with hyperphosphatemia
2013-000488-95Phase 3Completed
- Sponsor
- Medice
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hyperphosphatemia comparing Nicotinamide MR add-on arm with Placebo add-on arm (2 arms). Primary endpoint: Serum phosphate concentration (primary). Started Jul 2013; status: completed.
02
Drugs
nicotinamide
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on 2013-000488-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000488-95.